PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Platelet Aggregation 25,460 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.61
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
Pneumonia 81,521 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.55
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Epidermal Growth Factor Receptor 24,772 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
Ns3 3,189 Target Target A1AT 329 1 0.00 -1.00 0.00 0.61
Glomerulonephritis 23,459 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.60
C5a 4,164 Target Target A1AT 329 1 0.00 -1.00 0.00 0.60
Obesity 138,233 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.55
Chronic Obstructive Pulmonary Disease 27,780 Disease Target A1AT 329 22 0.01 -0.97 0.07 0.64
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
Shock 134,031 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.53
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
Bronchitis 18,336 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.60
Infection 766,637 Disease Target A1AT 329 16 0.00 -0.98 0.05 0.54
Diabetes 332,602 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.51
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
Adult Respiratory Distress Syndrome 4,034 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.62
CCL18 256 Target Target A1AT 329 2 0.01 -0.99 0.01 0.72
CD4 112,219 Target Target A1AT 329 1 0.00 -1.00 0.00 0.52
CD68 6,424 Target Target A1AT 329 2 0.00 -1.00 0.01 0.61
Cancer 1,053,491 Disease Target A1AT 329 34 0.00 -0.95 0.10 0.55
BNP 6,842 Target Target A1AT 329 1 0.00 -1.00 0.00 0.59
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
Hemorrhage 100,979 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.54
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
Cathepsin G 1,613 Target Target A1AT 329 2 0.00 -1.00 0.01 0.65
Carcinoma 433,099 Disease Target A1AT 329 22 0.00 -0.97 0.07 0.56
CEA 17,022 Target Target A1AT 329 8 0.00 -0.99 0.02 0.62
Myeloperoxidase 16,181 Target Target A1AT 329 3 0.00 -1.00 0.01 0.60
Sedimentation Rate 11,455 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.60
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Hyperbilirubinemia 5,757 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.61
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Hepatitis B 57,815 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.58